Pharmafile Logo

Confidential contracting

- PMLiVE

Newron back on track for Xadago approval in US

Italian firm is not required to conduct additional trials for its Parkinson’s disease drug

- PMLiVE

Lundbeck challenge to EC pay-for-delay ruling fails

Court upholds €94m fine for paying off firms to delay launch of Celexa generics

- PMLiVE

APCO Worldwide appoints chair of UK health practice

James Tyrrell joins London branch of global comms group

- PMLiVE

Pfizer appoints chief scientific officer

Dr Ole Isacson will lead the neuroscience research unit

- PMLiVE

Thornton & Ross Dermatology launches eczema consultation tool

Aims to help HCPs identify and tackle the impact of the skin condition

- PMLiVE

NHS promotes person-centred care in new dementia film

Highlights the importance of enabling people to live well with the condition

- PMLiVE

Retrophin rockets away as rare disease trial hits targets

Sparsentan has potential to become a blockbuster FSG drug, according to analysts

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Lucid Group Communications Limited

- PMLiVE

Merck closes in on first-line NSCLC label for Keytruda in US

Accelerated FDA review could see PD-1 inhibitor approved by the end of the year

Silence Therapeutics adds to leadership team

Dr Dmitry Samarsky and Dr Andy Richards join

- PMLiVE

Former Boehringer diabetes marketing VP joins Gelesis

Dr David Pass takes up the chief operating officer position

- PMLiVE

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links